Benjamin L. Palleiko - CHIEF EXECUTIVE OFFICER, Director at KalVista Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CHIEF EXECUTIVE OFFICER, Director
Issuer Symbol
KALV on Nasdaq
All Insider Reports
All Insider Reports

Benjamin L. Palleiko - trading volume in the past year for KalVista Pharmaceuticals, Inc.

Holdings reported by Benjamin L. Palleiko for KalVista Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 442,883 $6,894,271 $15.57 23 Feb 2026 Direct
Restricted Stock Unit 279,000 $1,878,760 $10.02 21 Feb 2026 Direct Common Stock
Employee Stock Option 113,920 11 Aug 2025 Direct Common Stock

Transactions reported by Benjamin L. Palleiko for KalVista Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.